2026年10月22日 20:50 ET 发布 · 更新于 22 天前 · 1 个来源
Food Allergy Biotech Firm Lycia Raises $317.5 Million in US IPO
bloomberg
·
原始报道
Lycia Therapeutics Inc., a biotechnology firm focused on treatments for allergies and autoimmune diseases, raised $317.5 million in an upsized US initial public offering that priced at the top of its marketed range.
原文